Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pain, Postoperative × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 28 Breast Neoplasms 28 Depression 25 Fatigue 17 Prostatic Neoplasms 12 Anxiety Disorders 12 Pain 8 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Colonic Neoplasms 6 Vomiting 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Nausea 5 Multiple Myeloma 5 Uterine Cervical Neoplasms 4 Lymphoma, Follicular 4 Lymphoma 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Burkitt Lymphoma 4 Testicular Neoplasms 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Dexmedetomidine 12 Bupivacaine 11 Ropivacaine 7 Saline Solution 6 Morphine 6 Injections, Epidural 5 Ketamine 4 Control Groups 4 Acetaminophen 4 Sodium Chloride 3 Pregabalin 3 Dental Occlusion 3 Anesthesia, General 3 Analgesia, Patient-Controlled 3 parecoxib 2 Tea 2 Surgical Procedures, Operative 2 Parapsychology 2 Gabapentin 2 Anesthetics, Local 2 thiamine triphosphorate 1 tetraethylpyrazine 1 salicylhydroxamic acid 1 oxycodone-acetaminophen 1 esmolol 1 Vitamins 1 Transcutaneous Electric Nerve Stimulation 1 Thoracic Surgery, Video-Assisted 1 Therapeutics 1 Tablets 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518085 2023-12-08

PREVENT

University of Oslo

Phase NA Completed

Data powered by HemOnc (CC BY 4.0) Colophon ⚡